Anti-epileptic drug linked to birth defects when taken with other drugs

June 07, 2016

In an analysis of pregnancies in Australia from 1999 to 2014 in which women were taking anti-epileptic drugs, fetal malformation rates fell over time in pregnancies where only one drug was taken, but rates increased in pregnancies where multiple drugs were taken.

The rise in such "polytherapy" malformation rates began around 2005 when levetiracetam and topiramate use began to increase. Malformation rates were similar in polytherapy pregnancies whether or not levetiracetam was included (7.14 percent versus 8.38 percent), but were higher in polytherapy pregnancies involving topiramate (14.94 percent versus 6.55 percent).

The findings suggest that use of topiramate in conjunction with other anti-epileptic drugs may enhance its propensity to cause fetal malformations. The mechanisms involved are currently unclear.

"Although the results are based on small numbers of patients in pregnancy, we suggest that the use of topiramate, at least in combination with other anti-epileptic medications, ought to be used with caution in women who plan to become pregnant," said Dr. Frank Vajda, lead author of the Epilepsia analysis.
-end-


Wiley

Related Topiramate Articles from Brightsurf:

Anti-obesity medications mitigate weight regain in RYGB surgery patients
Researchers have discovered that anti-obesity medications such as phentermine and topiramate, used individually or in combination, can significantly reduce weight regain in patients after Roux-en-Y gastric bypass surgery, according to a retrospective study published online in Obesity, the flagship journal of The Obesity Society.

Pharmacological migraine prophylaxis shows almost no effect in children
Migraines affect not only adults but frequently also children and adolescents.

New causative gene found in severe childhood epilepsy
A large international research team has discovered a new genetic cause for a severe, difficult-to-treat childhood epilepsy syndrome.

Just the right dose: antiepileptic drug clearance changes during pregnancy
Study finds significant changes in how seizure medications are metabolized during the different trimesters of pregnancy.

New position paper recommends treatment options for nightmare disorder in adults
A variety of treatment options may be effective for nightmare disorder in adults, according to a position paper from the American Academy of Sleep Medicine (AASM).

Topiramate in early pregnancy increases risk of oral clefts
A new study by investigators from Brigham and Women's Hospital and the Harvard T.H.

Does dosing of drug for mom make a difference for baby's risk of cleft lip, palate?
Taking a higher dose of topiramate during the first three months of pregnancy may increase a baby's risk of cleft lip or cleft palate more than when taking a lower dose, according to a study published in the Dec.

BOTOX® injections may provide relief for children and teens with hard-to-treat migraines
One in 10 school-aged children suffer from migraines, but there are few FDA-approved medications for them.

No magic pill to cure alcohol dependence yet
A new study published by the scientific journal Addiction has found no reliable evidence for using nalmefene, naltrexone, acamprosate, baclofen or topiramate to control drinking in patients with alcohol dependence or alcohol use disorder.

Compound derived from marijuana interacts with antiepileptic drugs
New research published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), suggests that an investigational neurological treatment derived from cannabis may alter the blood levels of commonly used antiepileptic drugs.

Read More: Topiramate News and Topiramate Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.